Table 2.
Variable | Dead | Surviving | p-value (log-rank) |
Gender | |||
Male | 9 | 24 | 0.99 |
Female | 3 | 9 | |
Age at diagnosis (months) | |||
< 48 | 3 | 10 | 0.90 |
≥ 48 | 9 | 23 | |
LDH (IU/L)* | |||
< 500 | 0 | 7 | 0.22 |
≥ 500 | 3 | 12 | |
Uric Acid (mg/dL)** | |||
< 7 | 3 | 25 | < 0.001 |
≥ 7 | 9 | 5 | |
Potassium (mEq/L)† | |||
< 4.2 | 3 | 15 | 0.96 |
≥ 4.2 | 3 | 14 | |
Serum creatinine (mg/dL)# | |||
< 0.8 | 8 | 25 | 0.34 |
≥ 0.8 | 4 | 7 | |
Weight-age Z-score | |||
< -1.28 | 3 | 12 | 0.50 |
≥ -1.28 | 9 | 21 | |
Height-age Z score) | |||
< -1.28 | 1 | 7 | 0.50 |
≥ -1.28 | 7 | 25 | |
Clinical stage†† | |||
I-II | 1 | 12 | 0.50 |
III-IV | 10 | 21 |
*Available for only 22 patients at diagnosis
**Available for 42 patients at diagnosis
† Available for 29 patients at diagnosis
†† Available for 44 patients at diagnosis - one patient died before staging
# Available for 40 patients at diagnosis